[OPINION] The HIV epidemic we saw coming — and can still stop
The Philippines’ surging HIV epidemic stems from health-system execution failures, not individual behavior. To reverse it, the DOH must urgently expand testing, treatment, and incentives.
-
-
Obesity, the Philippines’ new malnutrition problem
The trend points to a looming nutrition crisis. What changed?
-
[OPINION] Stop asking where UHC will find the money. Build the economy that can pay for it.
How do we make the Philippine economy itself capable of paying for increasingly expensive healthcare?
-
Before ASEAN gold, Baguio spent 60 years fighting smoke
In its long history of tobacco control, Baguio City has treated tobacco use as the public health issue that it is, and not merely as an enforcement issue
-
What do Filipinos want to hear from Marcos’ fifth SONA?
A Pulse Asia survey conducted from late June to early July asked Filipinos which issues they would most like President Ferdinand Marcos Jr. to discuss in his fifth State of the Nation Address
-
Johnson & Johnson announces $5.5-billion settlement of talc lawsuits
The deal must be accepted by 95% of the ovarian cancer claimants in state or federal court before it becomes final
-
[OPINION] Beyond the SONA, make healthcare a social commitment and economic strategy
Healthcare policy in the Philippines is framed primarily as an expenditure. We debate hospital budgets, insurance coverage, and annual appropriations. But it is also one of the world’s largest and fastest-growing economic sectors.
-
Long overdue IRR for early childhood care law finally signed
The implementing rules and regulations are signed over a year after Republic Act No. 12199 was enacted into law in May 2025
-
[EDITORIAL] ’Wag na ’wag nating sukuan ang pagbabantay sa pera ng bayan
Kapag walang mata ng publiko na nakatitig sa deliberasyon, kapag walang nag-iingay…aba, happy hour ang mga gustong bumalasubas sa badyet
-
Moderna, Merck breakthrough could usher in wave of cancer vaccines
Unlike chemotherapy, which kills both healthy and cancerous cells, or immunotherapy, which revs up the immune system, personalized cancer vaccines train the immune system to specifically target mutations found only on a person’s tumor
